Clinical Trials Browser

Phase 2 × Melanoma × Thymalfasin × Clear all

NCT00911443 2009-07-09

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Phase 2 Completed

488 enrolled 12 charts

Melanoma